Using Real‐World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic‐Pharmacodynamic Study

Using Real‐World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic‐Pharmacodynamic Study

Variation in response to biologic therapy for inflammatory diseases, such as psoriasis, is partly driven by variation in drug exposure. Real‐world psoriasis data were used to develop a pharmacokinetic/pharmacodynamic (PK/PD) model for the first‐line therapeutic antibody ustekinumab. The impact of di...

Full description

Bibliographic Details
Main Authors:	Shan Pan, Teresa Tsakok, Nick Dand, Dagan O. Lonsdale, Floris C. Loeff, Karien Bloem, Annick deVries, David Baudry, Michael Duckworth, Satveer Mahil, Angela Pushpa‐Rajah, Alice Russell, Ali Alsharqi, Gabrielle Becher, Ruth Murphy, Shyamal Wahie, Andrew Wright, Christopher E.M. Griffiths, Nick J. Reynolds, Jonathan Barker, Richard B. Warren, A. David Burden, Theo Rispens, Joseph F. Standing, Catherine H. Smith, on behalf of the BADBIR Study Group, the BSTOP Study Group, the PSORT Consortium
Format:	Article
Language:	English
Published:	Wiley 2020-03-01
Series:	Clinical and Translational Science
Online Access:	https://doi.org/10.1111/cts.12725

Similar Items

Psoriasis and Genetics
by: Nick Dand, et al.
Published: (2020-01-01)

The Association between Clinical Response to Ustekinumab and Immunogenicity to Ustekinumab and Prior Adalimumab.
by: Hsien-Yi Chiu, et al.
Published: (2015-01-01)

Review of the safety and efficacy of ustekinumab
by: Ellen J. Scherl, et al.
Published: (2010-09-01)

Late reaction to ustekinumab infusion
by: Marina Resener Morais, et al.
Published: (2013-09-01)

Ustekinumab: differential use in psoriasis
by: Uhlenhake EE, et al.
Published: (2011-07-01)

Efficacy and safety of ustekinumab in adolescents
by: Kellen R, et al.
Published: (2016-09-01)

Ustekinumab-induced fixed drug eruption
by: Dhafer M. Hafez, MD, et al.
Published: (2020-12-01)

Ustekinumab in the therapy of chronic plaque psoriasis
by: Jenna L O&rsquo;Neill, et al.
Published: (2009-03-01)

Ustekinumab for the treatment of psoriatic arthritis: an update
by: Davari P, et al.
Published: (2014-09-01)

Ustekinumab for the treatment of moderate to severe psoriasis
by: E Gospodarevskaya, et al.
Published: (2009-10-01)

Peritoneal tuberculosis in the setting of ustekinumab treatment for psoriasis
by: Maeve Lynch, MD, MBBChBAO, et al.
Published: (2017-05-01)

Plurifocal cutaneous leishmaniasis during treatment with ustekinumab
by: Louva Rakotonarivo, MD, et al.
Published: (2018-05-01)

Clinical utility of ustekinumab in Crohn’s disease
by: Kotze PG, et al.
Published: (2018-02-01)

The use of ustekinumab in refractory treatment of psoriatic arthritis
by: Vega Villanueva, Karen, et al.
Published: (2014)

Efficiency ustekinumab in the treatment of patients with psoriasis with metabolic disorders
by: I. V. Rychkova, et al.
Published: (2019-08-01)

Ustekinumab in patients with Crohn’s disease with extraintestinal manifestations (psoriasis)
by: P. A. Makarchuk, et al.
Published: (2020-10-01)

Hypophysitis following Treatment with Ustekinumab: Radiological and Pathological Findings
by: Ana M. Ramos-Leví, et al.
Published: (2018-03-01)

Emerging treatments in the management of psoriasis: biological targeting with ustekinumab
by: Marina Papoutsaki, et al.
Published: (2009-05-01)

Potential role of ustekinumab in the treatment of chronic plaque psoriasis
by: Santo Raffaele Mercuri, et al.
Published: (2010-05-01)

Recalcitrant psoriasis responding to new bilogic drug: Ustekinumab
by: Husein Husein-ElAhmed, et al.
Published: (2013-11-01)

Ustekinumab – nowy lek biologiczny w leczeniu łuszczycy
by: Joanna Salomon, et al.
Published: (2010-02-01)

Use of Ustekinumab in the Treatment of Libyan Psoriasis Vulgaris Patients
by: Beltammer Belkais, et al.
Published: (2019-03-01)

Enfermedad de Crohn metastásica tratada con ustekinumab
by: Rosa Ballester Sánchez, et al.
Published: (2021-02-01)

How to RESPOND to Modern Challenges for People Living with HIV: A Profile for a New Cohort Consortium
by: The RESPOND study The RESPOND study group
Published: (2020-07-01)

Successful Drug Desensitization to Ustekinumab in a Patient with Crohn’s Disease
by: Barrie Cohen, et al.
Published: (2021-07-01)

Ustekinumab is a new drug to treat psoriasis and psoriatic arthritis
by: Yuliya Leonidovna Korsakova, et al.
Published: (2013-04-01)

Ustekinumab for the treatment of Crohn’s disease: can it find its niche?
by: Ebby G. Simon, et al.
Published: (2016-01-01)

Multiple Clustered Dermatofibromas Following Ustekinumab Treatment for Psoriasis Vulgaris
by: Ricardo Ruiz-Villaverde, et al.
Published: (2017-08-01)

Rapid Induction and Maintenance of Remission in Refractory Ulcerative Colitis with Ustekinumab
by: An-Yu Chen, et al.
Published: (2019-09-01)

Cost-effectiveness of ustekinumab in moderate to severe Crohn’s disease in Sweden
by: Amanda Hansson-Hedblom, et al.
Published: (2018-08-01)

Ustekinumab for the treatment of recalcitrant pyoderma gangrenosum: A case report
by: Isabelle A Vallerand, et al.
Published: (2019-04-01)

A case report of heart failure after therapy with ustekinumab
by: Kourosh Beroukhim, et al.
Published: (2015-07-01)

Challenging Regional Psoriasis and Ustekinumab Biotherapy: Impact of the Patterns of Disease
by: Trinh Hermanns-Lê, et al.
Published: (2012-01-01)

Profile of ustekinumab and its potential in the treatment of active psoriatic arthritis
by: Montepaone M, et al.
Published: (2014-02-01)

Ustekinumab as an Alternative Treatment Option for Chronic Pityriasis Rubra Pilaris
by: Mudit Chowdhary, et al.
Published: (2015-03-01)

Is ustekinumab effective for psoriatic arthritis with insufficient response to initial treatment?
by: Soledad Venegas-Iribarren, et al.
Published: (2018-04-01)

Ustekinumab and Vedolizumab Dual Biologic Therapy in the Treatment of Crohn’s Disease
by: Eddie Y. Liu, et al.
Published: (2017-01-01)

THE TASK FORCE FOR THE MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS PRESENTING WITH ST-SEGMENT ELEVATION OF THE EUROPEAN SOCIETY OF CARDIOLOGY (ESC) 2017 ESC GUIDELINES FOR THEMANAGEMENT OF ACUTEMYOCARDIAL INFARCTION IN PATIENTS PRESENTING WITH ST-SEGMENT ELEVATION
by: Study Group ESC
Published: (2018-06-01)

IMPACT OF NICORANDIL IN ANGINA: SUBGROUP ANALYSES
by: IONA Study Group
Published: (2010-08-01)

Current trends in trachoma in a previously Hyperendemic area
by: Study Group The Trachoma
Published: (1998-01-01)